RACHAEL KENDALL: Open Payments
NPI 1740936111 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| ABBVIE INC. | 2 | $57 |
| PFIZER INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Caris MPI, Inc. | 1 | $33 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Cologuard Collection Kit, MI CANCER SEEK, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), QULIPTA, UBRELVY, AIRSUPRA, ELIQUIS, BREZTRI.
Industry payments across CA — which companies pay providers there.
